Stratos Wealth Partners LTD. Sells 319 Shares of IQVIA Holdings Inc. (NYSE:IQV)
Stratos Wealth Partners LTD. reduced its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 5.3% during the ...
Retirement Systems of Alabama Cuts Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)
Retirement Systems of Alabama cut its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 1.3% during the 4th ...
IQVIA Holdings (IQV) Gets a Buy from Morgan Stanley
In a report released today, Tejas Savant from Morgan Stanley maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price ...
IQVIA Holdings (IQV) Gets a Buy from RBC Capital
RBC Capital analyst Sean Dodge reiterated a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of $270.00. The ...
Opinion
Zacks Investment Research on MSN3hOpinion
Top Research Reports for Procter & Gamble, Boston Scientific & ConocoPhillips
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Co. (PG), Boston ...
AstraZeneca's cancer drug tops list of new brands launched in 2024
Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...
Pharmabiz15h
Lupin and Natco receive US FDA approval for generic Tracleer tablets for oral suspension
Lupin and Natco receive US FDA approval for generic Tracleer tablets for oral suspension: Our Bureau, Mumbai Monday, February 10, 2025, 15:45 Hrs [IST] Global pharma major Lupin L ...
Center for Biosimilars3h
Welcome Wezlana: Using Adalimumab to Predict Ustekinumab Market Potential
Amgen's Wezlana leading ustekinumab biosimilar launches, potentially driving savings and access, as highlighted by Dracey ...